Literature DB >> 10802292

In vivo T-cell subset depletion suggests that CD4+ T-cells and a humoral immune response are important for the elimination of orf virus from the skin of sheep.

J B Lloyd1, H S Gill, D M Haig, A J Husband.   

Abstract

In vivo lymphocyte subset depletion offers a unique opportunity to study the roles of different cellular components of the immune system of sheep during infection with orf virus. Lambs were depleted of specific lymphocyte subsets by the intravenous administration of monoclonal antibodies against ovine lymphocyte surface markers and then challenged with orf virus. The skin lesions that developed were scored visually as to their severity. Blood samples were collected to monitor the lymphocyte depletions and to measure orf-virus-specific antibody levels. Skin biopsies were collected from the lesion site and studied to determine the course of the infection and the presence of various cell types and orf virus. All the sheep developed orf virus lesions after infection. All three of the CD4-depleted lambs were unable to clear virus from their skin and did not have an antibody response to the virus. Virus was also detected in the skin of one each of the three CD8-depleted, WC1-depleted and control sheep on the final day of the trial. CD8(+) lymphocytes did not appear to be essential for viral clearance later in the infection. Depletion of the majority of gammadelta(+) T-cells did not affect the outcome of orf virus infection. In sheep with high orf-virus-specific antibody titres at the time of infection, orf lesions healed faster than lesions in sheep with low antibody levels, and this occurred regardless of the lymphocyte depletion status of the animals. This study suggests that the presence of CD4(+) T-cells and orf-virus-specific antibodies are important for the control of viral replication in the skin of infected sheep.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10802292     DOI: 10.1016/s0165-2427(00)00178-1

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  6 in total

1.  Orf virus encodes a novel secreted protein inhibitor of granulocyte-macrophage colony-stimulating factor and interleukin-2.

Authors:  D Deane; C J McInnes; A Percival; A Wood; J Thomson; A Lear; J Gilray; S Fleming; A Mercer; D Haig
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

2.  Novel recombinant parapoxvirus vectors induce protective humoral and cellular immunity against lethal herpesvirus challenge infection in mice.

Authors:  Timo Fischer; Oliver Planz; Lothar Stitz; Hanns-Joachim Rziha
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

Review 3.  Molecular genetic analysis of orf virus: a poxvirus that has adapted to skin.

Authors:  Stephen B Fleming; Lyn M Wise; Andrew A Mercer
Journal:  Viruses       Date:  2015-03-23       Impact factor: 5.048

4.  Dermatopathology of Orf Virus (Malaysian Isolates) in Mice Experimentally Inoculated at Different Sites with and without Dexamethasone Administration.

Authors:  Jamilu Abubakar Bala; Krishnan Nair Balakrishnan; Ashwaq Ahmed Abdullah; Tay Kimmy; Yusuf Abba; Ramlan Bin Mohamed; Faez Firdaus Abdullah Jesse; Abd Wahid Haron; Mustapha Mohamed Noordin; Asinamai Athliamai Bitrus; Idris Umar Hambali; Mohd Azmi Mohd Lila
Journal:  J Pathog       Date:  2018-08-01

5.  Recombinant B2L and Kisspeptin-54 DNA Vaccine Induces Immunity Against Orf Virus and Inhibits Spermatogenesis In Rats.

Authors:  Teketay Wassie; Zeng Fanmei; Xunping Jiang; Guiqiong Liu; Shishay Girmay; Zhang Min; Liu Chenhui; Dong Dong Bo; Sohail Ahmed
Journal:  Sci Rep       Date:  2019-11-07       Impact factor: 4.379

6.  Orf Virus-Based Vaccine Vector D1701-V Induces Strong CD8+ T Cell Response against the Transgene but Not against ORFV-Derived Epitopes.

Authors:  Alena Reguzova; Michael Ghosh; Melanie Müller; Hanns-Joachim Rziha; Ralf Amann
Journal:  Vaccines (Basel)       Date:  2020-06-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.